Game-Changer: New MOU Sparks Rapid Growth in Plasma Medicine Industry

Game-Changer: New MOU Sparks Rapid Growth in Plasma Medicine Industry

In a significant move towards enhancing healthcare in Iran, a trilateral memorandum of understanding (MOU) has been established to elevate the country’s role in the plasma medicine industry. This initiative is a crucial step in integrating new technologies into healthcare systems, aiming to improve patient outcomes and access to advanced medical treatments.

Signed by key officials including Saeed Sarkar from the Vice-Presidency for Science and Technology, Shahin Akhoundzadeh from the Ministry of Health, and Mahdiyeh Bakhtiari, the CEO of the Plasma Therapy Knowledge-Based Company, the MOU focuses on several critical objectives:

  • Developing and implementing extensive multi-center research in plasma medicine.
  • Integrating advanced technology into official treatment protocols across the nation.
  • Conducting impactful projects to treat hard-to-cure diseases.
  • Improving health services and providing access to cutting-edge medical technologies.

This memorandum signifies a national movement that harnesses the scientific, research, and technological capabilities of Iran. It aims to expand the use of emerging technologies within the medical field, which is essential for advancing healthcare standards.

First Indigenous Plasma Therapy Clinic

In a parallel development, the Atomic Energy Organization of Iran (AEOI), in collaboration with Jahrom University of Medical Sciences in southern Fars province, inaugurated the first cold plasma therapy clinic tailored for wound treatment using domestic technology. Launched in April, this clinic represents a significant milestone in the application of plasma therapy in the country.

During the clinic’s opening ceremony, AEOI head Mohammad Eslami emphasized the achievement as a testament to Iran’s scientific progress and national self-confidence. He pointed out that nuclear technology is pivotal not only in medical services but also in agriculture.

Eslami remarked, “The inauguration of this clinic can help expand plasma therapy technology in other medical centers in the country.” This initiative is expected to pave the way for utilizing nuclear technologies in cancer treatment and other health areas, as expressed by Hossein Hakimelahi, chancellor of Jahrom University of Medical Sciences.

Advancements in Plasma Medicine

On August 26, Eslami highlighted that advancements in heavy water derivatives and plasma medicine are ushering in new possibilities for drug development and medical treatments. This reflects a significant leap in applying nuclear technology to enhance public health.

Under the auspices of a new MOU with the Ministry of Health, clinical trials that were previously centralized at Tehran University will now extend to select universities nationwide. Eslami stated, “This will accelerate the spread of plasma-based technologies to different provinces, ensuring that all Iranians can benefit equally and simultaneously from these advances.”

These comments were made during National Doctors Day celebrations, where Eslami also shared the AEOI’s notable success in producing over 70 types of radiopharmaceuticals. These are currently supplied to more than 220 nuclear medicine centers across Iran and are even exported internationally.

The produced radiopharmaceuticals can be categorized into three main types:

  1. Diagnostic: These advancements are pushing the frontiers of knowledge and improving the precision of patient examinations.
  2. Therapeutic: This category focuses on alleviating patients’ suffering while providing more effective treatment options.
  3. Palliative: These products are essential for enhancing the quality of life for patients with serious illnesses.

Eslami further revealed that around 20 additional radiopharmaceuticals are currently under research and in clinical trial phases. This reflects Iran’s expanding capability to integrate nuclear science into its healthcare system, positioning the country at the forefront of medical innovation.

The developments in plasma medicine and radiopharmaceutical production mark a significant advancement in Iran’s healthcare landscape, promising improved patient care and treatment options for various medical conditions.

Similar Posts

  • This article will be expanded soon. This article will be expanded soon. This article will be expanded with more detailed information shortly. This article will be expanded with more detailed information shortly. This article will be expanded with more detailed information shortly. This article will be expanded with more detailed information shortly.

  • Leading Knowledge-Based Companies Showcase Innovations at Afghan Health Exhibition

    From December 2 to 4, forty Iranian knowledge-based firms are participating in the Afghan Health Exhibition in Kabul, showcasing their healthcare innovations and aiming to strengthen ties between Iran and Afghanistan. Mehdi Pirsalehi, head of Iran’s Food and Drug Administration, will support these firms and engage in talks with Afghan health officials to enhance collaboration in the health sector. Iran’s government prioritizes self-sufficiency in medicine and medical equipment, with over 70% of such items produced domestically. The exhibition allows Iranian manufacturers to expand their market presence and reinforces their commitment to improving healthcare outcomes in the region.

  • Health Minister Announces Exciting Relaunch of Family Physician Program This Year!

    The Family Physician Program is set to launch in Iran during the current year, aiming to enhance healthcare delivery through reforms and better patient pathways. Health Minister Mohammad-Reza Zafarqandi emphasized the need for collaboration among stakeholders and the establishment of a national headquarters for effective management. The program, which originated in 2005, focuses on improving access to healthcare in smaller communities and includes services like health examinations, mental health support, and 24/7 care. Currently, it covers 182 cities, benefiting over 20 million Iranians, and seeks to modernize the healthcare system through preventive care and systematic support.

  • Tehran and Khartoum Forge New Pathways to Strengthen Scientific Collaboration

    Iran’s Organization of Student Affairs head, Saeed Habiba, met with Sudan’s Ambassador Abdulaziz Hassan Saleh Taha to enhance scientific collaborations and educational opportunities for Sudanese students in Iran. Taha emphasized the cultural and historical ties between the two nations and expressed interest in strengthening their relationship, particularly in education. Habiba highlighted the high global rankings of Iranian universities and announced plans to admit self-funded Sudanese students and offer scholarships. Additionally, discussions between Taha and Iran’s National Institute of Genetic Engineering and Biotechnology focused on cooperation in health issues, including cancer treatment and disease control, further solidifying educational and scientific ties.

  • Iran Takes the Helm: Elected as Next Chair of APDIM Governing Council

    The Asian and Pacific Centre for the Development of Disaster Information Management (APDIM) held its Ninth Session of the Governing Council in Tehran on January 22, 2025, where Iran was elected as the new Chair, succeeding Tajikistan. Delegates from various member countries, including Bangladesh, India, and China, gathered to discuss advancements in disaster information management, capacity building, and regional cooperation. The session resulted in the adoption of APDIM’s program for 2025 and a review of its activities. The meeting reinforced APDIM’s commitment to enhancing disaster management and resilience-building in the Asia-Pacific region, aligning with Sustainable Development Goals.

  • Tehran Urges ROPME to Integrate Sustainable Development Strategies into Strategic Plan

    Iran has proposed incorporating the fight against sand and dust storms (SDSs) into the Regional Organization for the Protection of Marine Environment’s (ROPME) strategic plan during the 38th executive committee meeting in Kuwait. Ahmad-Reza Lahijanzadeh from Iran’s Department of Environment emphasized the importance of integrating SDSs into climate change discussions, even if not officially recognized as a separate axis. The meeting addressed Persian Gulf pollution, climate change, and biodiversity preservation, with ongoing virtual meetings planned for further development. Enhanced regional cooperation is essential for effective environmental strategies, aiming to protect marine resources and address climate challenges collaboratively.